We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00184860
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 27, 2007
Information provided by:
Radboud University

Brief Summary:

Technical developments in radiation oncology are making it possible to deliver a prescribed radiation dose to radiation target volume with increasing accuracy.

Therefore it is becoming even more relevant to accurately define the radiation target volumes.

The current standard in defining radiation target volumes in patients with head-and-neck cancer is to combine physical examination data with a CT-scan in the treatment position.

The goal of this investigation is to analyse the rol of CT-PET-MRI image fusion in defining radiation target volumes.

Condition or disease Intervention/treatment
Head and Neck Neoplasms Procedure: PET-scan, MRI-scan

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Value of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes in Patients With a Squamous Cell Carcinoma of the Head-and-Neck Region, Who Are to be Treated With Definitive Radiotherapy
Study Start Date : June 2003

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Patients eligible for definitive radiotherapy with a Head and Neck Neoplasm (squamous cell carcinoma) in one of the following anatomical sites:

  • oral cavity
  • oropharynx
  • hypopharynx
  • larynx

Exclusion Criteria:

  • age < 18 years
  • pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184860

Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500HB
Sponsors and Collaborators
Radboud University
Study Director: Johannes H Kaanders, MD. PhD Radiation oncologist, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

ClinicalTrials.gov Identifier: NCT00184860     History of Changes
Other Study ID Numbers: 2004/153
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: April 27, 2007
Last Verified: April 2007

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site